← Evidence map

ArticleDermatology and therapy2025

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of OBI-858 for the Treatment of Moderate-to-Severe Glabellar Lines.

Yu-Hsiu Yen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of OBI-858 for the Treatment of Moderate-to-Severe Glabellar Lines. | OpenQuestion